2102
R. Fujiwara, S. Horito / Carbohydrate Research 346 (2011) 2098–2103
70.70; H, 6.55; S, 6.51. Found: C, 70.54; H, 6.67; S, 6.44. For 1H and
13C NMR data see Tables 3 and 4, respectively.
3.7.2. Analytical data and spectral data for 6b
D +16.6 (c 1.08, CHCl3); 1H NMR (CDCl3): d 8.14–7.21 (m, 20H,
[a]
4Ph), 5.84 (dd, 1H, J3,4 3.0 Hz, J4,5 1.1 Hz, H-4), 4.90 (d, 1H, CHHPh),
4.83 (d, 1H, CHHPh), 4.74 (d, 1H, CHHPh), 4.59 (dd, 1H, H-6a), 4.59
(d, 1H, CHHPh), 4.47 (d, 1H, J1,2 7.6 Hz, H-1), 4.36 (dd, 1H, H-6b),
4.12 (q, 2H, OCH2CH3), 4.00–3.96 (m, 2H, H-5, OCHHCH2), 3.74–
3.68 (m, 2H, H-2, H-3), 3.57 (m, 1H, OCHHCH2), 2.27 (t, 2H,
CH2CH2COO), 1.74–1.57 (m, 4H, OCH2CH2, CH2CH2COO), 1.45–
1.24 (m, 8H, 4CH2CH2CH2), 1.25 (t, 3H, CH2CH3); 13C NMR (CDCl3):
d 173.9, 166.2, 165.9, 138.5, 137.8, 133.3, 130.1, 129.8, 129.7,
128.5, 128.3, 128.1, 128.0, 127.6, 104.0 (C-1), 79.3 (C-3), 79.0 (C-
2), 75.4 (CH2Ph), 72.2 (CH2Ph), 71.0 (C-5), 70.6 (COCH2CH2), 67.4
(C-4), 62.6 (C-6), 60.2 (CH2CH3), 34.4 (CH2CH2COO), 29.7, 29.3,
29.1, 26.1, 25.0, 14.3 (OCH2CH3). Anal. Calcd for C45H52O10
(752.89): C, 71.79; H, 6.96. Found: C, 71.55; H, 6.93.
3.5. General glycosylation procedure
A mixture of donor (1.00 mmol) and alcohol (1.50 mmol) in dry
solvent (for dehydration, 5.0 mL) was dried by azeotropic dehydra-
tion under Ar for 2 h and was then concentrated. The mixture was
dissolved in dry solvent (reaction, 5.0 mL) and cooled to the pre-
sented temperature (Tables 1 and 2). Molecular sieves (4 Å,
0.50 g), NIS (2.70 mmol), and AgOTf (0.10 mmol) were added to
the mixture, and the reaction was stirred at the same temperature
for 1–2 h. The reaction was quenched with Et3N. The precipitate
was filtered through a pad of Celite. The filtrate and washings were
combined, and the solution was successively washed with satd aq
NaHCO3, 1 M Na2S2O3, and satd aq NaCl, dried and concentrated.
The residue was purified by flash column chromatography to yield
the products.
3.8. 8-Ethoxycarbonyloctyl 4-O-benzoyl-2,3-di-O-benzyl-
fucopyranoside (12 ) and 8-ethoxycarbonyloctyl 4-O-benzoyl-
2,3-di-O-benzyl-b- -fucopyranoside (12b)
a-L-
a
L
3.6. 8-Ethoxycarbonyloctyl 3,4-di-O-benzoyl-2-O-benzyl-
fucopyranoside (3 ) and 8-ethoxycarbonyloctyl 3,4-di-O-
benzoyl-2-O-benzyl-b- -fucopyranoside (3b)
a-L-
Compound 1 (186 mg, 0.92 mmol), 9 (302 mg, 0.61 mmol), NIS
(370 mg, 1.65 mmol), and AgOTf (16.0 mg, 61.5 mol) were re-
acted as described in Section 3.5. The anomers were then purified
a
l
L
using flash column chromatography (1:8 EtOAc–hexane) to afford
Compound 1 (322 mg, 1.59 mmol), 2 (532 mg, 1.06 mmol), NIS
(640 mg, 2.86 mmol), and AgOTf (27.0 mg, 0.110 mmol) were re-
acted as described in Section 3.5. The anomers were then purified
using flash column chromatography (1:8 EtOAc–hexane) to afford
12a (251 mg, 65%) and 12b (113 mg, 29%) as colorless syrups.
3.8.1. Analytical data for 12
a
[a]
D À77.0 (c 0.92, CHCl3). Anal. Calcd for C38H48O8 (632.78): C,
3a
(562 mg, 82%) and 3b (89.0 mg, 13%) as colorless syrups.
72.13; H, 7.65. Found: C, 72.18; H, 7.72. For 1H and 13C NMR data
see Tables 3 and 4, respectively.
3.6.1. Analytical data for 3
a
[
a
]
À143 (c 0.99, CHCl3). Anal. Calcd for C38H46O9 (646.77): C,
D
3.8.2. Analytical data for 12b
70.57; H, 7.17. Found: C, 70.77; H, 7.21. For 1H and 13C NMR data
see Tables 3 and 4, respectively.
[a]
D À60.9 (c 1.06, CHCl3). Anal. Calcd for C38H48O8 (632.78): C,
72.13; H, 7.65. Found: C, 72.02; H, 7.69. For 1H and 13C NMR data
see Tables 3 and 4, respectively.
3.6.2. Analytical data for 3b
[
a
]
À132 (c 1.04, CHCl3). Anal. Calcd for C38H46O9 (646.77): C,
D
3.9. 8-Ethoxycarbonyloctyl 2-O-benzyl-3,4-O-isopropylidene-
-fucopyranoside (13 ) and 8-ethoxycarbonyloctyl 2-O-benzyl-
3,4-O-isopropylidene-b- -fucopyranoside (13b)
a-
70.57; H, 7.17. Found: C, 70.52; H, 6.75. For 1H and 13C NMR data
see Tables 3 and 4, respectively.
L
a
L
Compound 1 (462 mg, 2.28 mmol), 1026 (378 mg, 1.52 mmol),
NIS (920 mg, 4.10 mmol), and AgOTf (39.0 mg, 0.150 mmol) were
reacted as described in Section 3.5. The anomers were then puri-
fied using flash column chromatography (1:8 EtOAc–hexane) to af-
3.7. 8-Ethoxycarbonyloctyl 4,6-di-O-benzoyl-2,3-di-O-benzyl-
-galactopyranoside (6 ) and 8-ethoxycarbonyloctyl 4,6-di-O-
benzoyl-2,3-di-O-benzyl-b- -galactopyranoside (6b)
a-
D
a
D
Compound 1 (462 mg, 2.28 mmol), 1026 (378 mg, 1.52 mmol),
NIS (920 mg, 4.10 mmol), and AgOTf (39.0 mg, 0.150 mmol) were
reacted as described in Section 3.5. The anomers were then purified
using flash column chromatography (1:8 EtOAc–hexane) to afford
ford 13a (356 mg, 49%) and 13b (240 mg, 33%) as colorless syrups.
3.9.1. Analytical data for 13
a
[a]
D À75.8 (c 1.00, CHCl3). Anal. Calcd for C27H42O7 (478.62): C,
67.76; H, 8.84. Found: C, 67.90; H, 8.79. For 1H and 13C NMR data
see Tables 3 and 4, respectively.
13a (356 mg, 49%) and 13b (240 mg, 33%) as colorless syrups.
3.7.1. Analytical and spectral data for 6
a
[a]
D +40.3 (c 1.04, CHCl3); 1H NMR (CDCl3): d 8.06–7.22 (m, 20H,
3.9.2. Analytical data for 13b
4Ph), 5.90 (dd, 1H, J3,4 3.4 Hz, J4,5 0.8 Hz, H-4), 4.90 (d, 1H, J1,2
3.4 Hz, H-1), 4.85 (d, 1H, CHHPh), 4.83 (d, 1H, CHHPh), 4.66 (d,
1H, CHHPh), 4.62(d, 1H, CHHPh), 4.46 (m, 1H, H-6a), 4.38–4.33
(m, 2H, H-5, H-6b), 4.12 (m, 3H, H-3, CH2CH3), 3.94 (dd, 1H, J2,3
10.2 Hz, H-2), 3.65 (m, 1H, OCHHCH2), 3.48 (m, 1H, OCHHCH2),
2.27 (t, 2H, CH2CH2COO), 1.66–1.56 (m, 4H, OCH2CH2,
CH2CH2COO), 1.32–1.21 (m, 8H, 4CH2CH2CH2), 1.25 (t, 3H,
OCH2CH3,); 13C NMR (CDCl3): d 173.9, 166.1, 165.8, 138.5, 138.1,
133.2, 133.2, 130.0, 129.8, 129.7, 128.5, 128.4, 128.3, 128.2,
128.1, 127.9, 127.7, 127.5, 97.8 (C-1), 76.4 (C-2), 75.2 (C-3), 73.5
(CH2Ph), 72.1 (CH2Ph), 68.8 (C-4), 68.6 (COCH2CH2), 67.1 (C-5),
63.3 (C-6), 60.2, 34.4 (CH2CH2COO), 29.4, 29.2, 29.1, 26.1, 25.0,
14.3 (OCH2CH3). Anal. Calcd for C45H52O10 (752.89): C, 71.79; H,
6.96. Found: C, 71.57; H, 6.97.
[a] –47.6 (c 1.03, CHCl3). Anal. Calcd for C27H42O7 (478.62): C,
D
67.76; H, 8.84. Found: C, 68.04; H, 8.71. For 1H and 13C NMR data
see Tables 3 and 4, respectively.
3.10. Decyl 3,4-di-O-benzoyl-2-O-benzyl-
(14 ) and decyl 3,4-di-O-benzoyl-2-O-benzyl-b-
fucopyranoside (14b)
a-L-fucopyranoside
a
L-
Compound 7 (147 mg, 0.93 mmol), 2 (298 mg, 0.59 mmol), NIS
(370 mg, 1.67 mmol), and AgOTf (15.0 mg, 58.4 mol) were re-
l
acted as described in Section 3.5. The anomers were then purified
using flash column chromatography (1:20 EtOAc–hexane) to afford
a (250 mg, 71%) as a colorless syrup and 14b (62 mg, 18%) as a
colorless syrup.
14